A Bionews survey of 311 people living with the disease finds that three emotions explain 63% of all variation in mental ...
CRF awards four global grants to advance CHM research toward new clinical trial endpoints and therapeutic approaches—driving progress toward treatments.
Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the very early stages of Alzheimer's disease. Published in Translational ...
At the HIMSS26 AI in Healthcare Forum, MGB's chief information and digital officer described strategies for governance, safety and sustainability as it strives to integrate artificial intelligence ...
DT Research will showcase the DT574 medical-grade All-in-One (AIO) computer and the WebDT Battery Fleet Manager at the HIMSS 2026 Global Health Conference and Exhibition in booth 1964, March 10-12, in ...
Fred Hutch Cancer Center hematologists took center stage at the 2026 Tandem Meetings, a multidisciplinary meeting of experts in the field of blood stem cell transplantation, held in Salt Lake City ...
Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...
New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...
Cardiovascular endocrinology has entered a period of rapid expansion, driven by advances in molecular profiling, translational therapeutics, and integrative ...
Human brain health research is moving beyond universal “norms” toward models that treat culture, language, environment, and structural conditions as central ...
Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance.
Chinese Neurosurgical Journal highlights gut–brain axis in pituitary tumor–related cognitive decline
A new study from Kunming Medical University suggests that hormonal imbalance and gut microbiota alterations may contribute to cognitive decline in patients with pituitary neuroendocrine tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results